Pegozafermin Is a Potential Master Therapeutic Regulator in Metabolic Disorders: A Review.

Bailey, Nadian N; Peterson, Stephen J; Parikh, Manish A; Jackson, Kaedrea A; Frishman, William H

Bailey, Nadian N; Peterson, Stephen J; Parikh, Manish A; Jackson, Kaedrea A; Frishman, William H.

Afiliación

Bailey NN; From the Department of Medicine, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY.
Peterson SJ; From the Department of Medicine, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY.
Parikh MA; Weill Department of Medicine, Weill Cornell Medicine, New York, NY.
Jackson KA; From the Department of Medicine, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY.
Frishman WH; Weill Department of Medicine, Weill Cornell Medicine, New York, NY.

Cardiol Rev ; 2023 Oct 27.

Article en En | MEDLINE | ID: mdl-37889055

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cardiol Rev Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google